Regulation of CD30 Antigen Expression and Its Potential Significance for Human Disease
- 1 May 2000
- journal article
- editorial
- Published by Elsevier in The American Journal of Pathology
- Vol. 156 (5) , 1479-1484
- https://doi.org/10.1016/s0002-9440(10)65018-3
Abstract
No abstract availableKeywords
This publication has 98 references indexed in Scilit:
- A Murine Xenograft Model for Human CD30+ Anaplastic Large Cell LymphomaThe American Journal of Pathology, 1999
- Opposite role for interleukin‐4 and interferon‐γ on CD30 and lymphocyte activation gene‐3 (LAG‐3) expression by activated naive T cellsEuropean Journal of Immunology, 1997
- Circulating skin-homing T cells in atopic dermatitis. Selective up-regulation of HLA-DR, interleukin-2R, and CD30 and decrease after combined UV-A and UV-B phototherapyArchives of Dermatology, 1996
- CD30 Contains Two Binding Sites with Different Specificities for Members of the Tumor Necrosis Factor Receptor-associated Factor Family of Signal Transducing ProteinsPublished by Elsevier ,1996
- Activation of HIV expression by CD30 triggering in CD4+ T cells from HIV-infected individualsImmunity, 1995
- Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite InstabilityScience, 1995
- Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders: A proposal for classification and guidelines for management and treatmentJournal of the American Academy of Dermatology, 1993
- Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's diseaseCell, 1992
- Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradoxCell, 1991
- Germinal center cells express bcl‐2 protein after activation by signals which prevent their entry into apoptosisEuropean Journal of Immunology, 1991